Europe Wound Care Biologics Market to 2025 - Opportunities in 3D Skin Printing
DUBLIN, Oct. 5, 2018 /PRNewswire/ --
The "Europe Wound Care Biologics Market: Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
Europe wound care biologics market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Prominent factors driving the growth of this market consist of increasing incidence of foot ulcers, increasing incidence of burn cases, rising number of geriatric population, innovation in wound care biologics are fuel the growth of wound care biologics market.
On the basis of product type the Europe wound care biologics market is segmented into synthetic skin grafts segment, growth factors segment, allografts segment, xenografts segment. In 2018, synthetic skin grafts segment is expected to dominate the Europe wound care biologics market with highest market shares. However, allografts segment is expected to grow at the highest CAGR in the forecast period. Growth factors segment is further sub segmented into platelet-derived growth factor (PDGF) segment, platelet rich plasma (PRP) segment, epidermal growth factor (EGF) segment and basic fibroblast growth factor (BFGF) segment, granulocyte colony stimulating factor (G-CSF) segment, talactoferrin alfa segment, thrombin peptide (TP508) segment, keratinocyte growth factor (KGF) segment.
On the basis of wound type the Europe wound care biologics market is categorized into wounds, and ulcers, burns. In 2018, wounds segment is expected to dominate the Europe wound care biologics market with the highest market shares. However, ulcers segment is expected to grow at the highest CAGR in the forecast period.
On the basis of end user Europe wound care biologics market is segmented into hospitals, wound care centres and ambulatory centers, clinics, community healthcare centers. In 2018, hospitals segment is expected to dominate the Europe wound care biologics market with the highest CAGR in the forecast period 2018 to 2025.
Key Topics Covered:
1 Introduction
2 Market Segmentation
3 Market Overview
3.1 Drivers
3.1.1 Increasing Cases Of Diabetic Foot Ulcers
3.1.2 Increasing Incidences Of Burn Cases
3.1.3 Rising Number Of Geriatric Population
3.1.4 Innovation In Wound Care Biologics
3.1.5 New Product Launches
3.2 Restrains
3.2.1 High Cost Of Wound Treatment And Wound Care Biologics
3.2.2 Risk Of Skin Substitute Failure
3.3 Opportunities
3.3.1 3D Skin Printing
3.3.2 Awareness Programs
3.4 Challenges
3.4.1 Lack Of Wound Management Services
4 Executive Summary
5 Premium Insights
6 Europe Wound Care Biologics Market, By Product Type
6.1 Overview
6.2 Synthetic Skin Grafts
6.3 Growth Factors
6.3.1 Platelet Derived Growth Factor (PDGF)
6.3.2 Platelet Rich Plasma (PRP)
6.3.3 Epidermal Growth Factors (EGF)
6.3.4 Basic Fibroblast Growth Factors (BFGF)
6.3.5 Granulocyte Colony Stimulating Factor (G-CSF)
6.3.6 Talactoferrin Alfa
6.3.7 Thrombin Peptide
6.3.8 Keratinocy Growth Factor (KGF)
6.4 Allografts
6.5 Xenografts
7 Europe Wound Care Biologics Market, By Wound Type
7.1 Overview
7.2 Wounds
7.2.1 Surgical Wound
7.2.1.1 Skin Surgery
7.2.1.1.1 Wound Closure
7.2.1.1.2 Skin Biopsy
7.2.1.1.3 Skin Flap
7.2.1.1.4 Skin Graft
7.2.1.1.5 Others
7.2.1.2 Cosmetic Procedure
7.2.1.2.1 breast Enhancement
7.2.1.2.2 Facial Contouring
7.2.1.2.3 Facial Rejuvenation:
7.2.1.2.4 Body Contouring
7.2.1.2.5 Skin Rejuvenation
7.2.1.2.6 Others
7.2.1.3 Gynecologic Procedures
7.2.1.3.1 Pubovaginalis Sling
7.2.1.3.2 Pelvic Floor Reconstruction
7.2.1.3.3 Rectocele Repair Surgery
7.2.1.3.4 Others
7.2.1.4 Gastrointestinal Procedure
7.2.1.4.1 General Gastrointestinal Surgery
7.2.1.4.2 Hernia
7.2.1.4.3 Others
7.2.2 Acute Wounds
7.2.3 Chronic Wounds
7.2.4 Traumatic Wounds
7.3 Burns
7.3.1 Ulcers
7.3.2 Diabetic Ulcers
7.3.3 Pressure Ulcer
7.3.4 Venous Ulcer
7.3.5 Others
8 Europe Wound Care Biologics Market, By End User
8.1 Overview
8.2 Hospitals
8.3 Wound Care Centers
8.4 Ambulatory Surgical Centers
8.5 Clinics
8.6 Community Healthcare Center
9 Europe Wound Care Biologics Market: Geography
9.1 Europe
9.1.1 Germany
9.1.2 France
9.1.3 U.K.
9.1.4 Italy
9.1.5 Switzerland
9.1.6 Netherlands
9.1.7 Russia
9.1.8 Turkey
9.1.9 Spain
9.1.10 Belgium
9.1.11 Rest Of Europe
10 Europe Wound Care Biologics Market, Company Landscape
10.1 Company Share Analysis: Europe
11 Company Profiles
-- MiMedx
-- Organogenesis Inc.
-- Integra LifeSciences
-- ConvaTec Inc.
-- Smith and Nephew
-- Integra Life Sciences Corporation
-- Mlnlycke Health Care AB
For more information about this report visit https://www.researchandmarkets.com/research/dtsm7q/europe_wound_care?w=5
Media Contact:
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/europe-wound-care-biologics-market-to-2025---opportunities-in-3d-skin-printing-300725111.html
SOURCE Research and Markets
